Your browser doesn't support javascript.
loading
Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.
Hosseini, Seyed Samad; Khalili, Saeed; Baradaran, Behzad; Bidar, Negar; Shahbazi, Mohammad-Ali; Mosafer, Jafar; Hashemzaei, Mahmoud; Mokhtarzadeh, Ahad; Hamblin, Michael R.
Afiliação
  • Hosseini SS; Department of Biotechnology, Higher Education Institute of Rab-Rashid, Tabriz, Iran.
  • Khalili S; Department of Biology Sciences, Faculty of Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran.
  • Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Bidar N; Department of Biotechnology, Higher Education Institute of Rab-Rashid, Tabriz, Iran.
  • Shahbazi MA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Mosafer J; Nanotechnology Research center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical Biotechnology, School of Paramedical Science, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
  • Hashemzaei M; Department of Pharmacodynamics and Toxicology, School of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.
  • Mokhtarzadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.
  • Hamblin MR; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA; Department of Dermatology, Harvard Medical School, Boston, MA, 02115, USA; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa. Electronic address: hamb
Int J Biol Macromol ; 167: 1030-1047, 2021 Jan 15.
Article em En | MEDLINE | ID: mdl-33197478

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Terapia de Alvo Molecular / Antineoplásicos Imunológicos / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Animals / Humans Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Terapia de Alvo Molecular / Antineoplásicos Imunológicos / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Animals / Humans Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã